2023-06-29 05:51:19
(Alliance News) – Svas Biosana Spa announced on Wednesday that the boards of directors of the parent company and its subsidiary Mark Medical Spa have approved the issuance of two bond issues of 10 million euros and 3 million euros , respectively.
Mark Medical’s €3 million loan is covered by an independent personal guarantee on first demand from the parent company, for a minimum period of six years and a maximum of seven years. Through this instrument, the Svas Group will have the opportunity to raise long-term financial resources, under competitive economic conditions, in order to support investments and growth initiatives, as the company explains.
The issuance is expected to take place in July and the two bonds, intended for subscription by accredited investors, will mature in December 2029, with an amortization schedule and a pre-amortization period.
Umberto Perillo, CEO of Svas Biosana, said: “The vocation of growth and internationalization is an integral part of the company’s strategy. Thanks to this operation, we will have additional resources to finance our industrial development programs and the ‘expanding our activities abroad’.
The action of Svas Biosana closed Wednesday down 1.3% to 7.60 euros per share.
Par Giuseppe Fabio Ciccomascolo, senior journalist of Alliance News
Comments and questions to redazione@alliancenews.com
2023 Alliance News IS Italian Service Ltd. All rights reserved.
1688027883
#Svas #Biosana #finances #growth #bond #issues #total #amount #million #euros
